Abbott Gets a Stent--But What Else?
Abbott Laboratories has licensed US co-promotion rights to Biocompatibles International's coated stents and certain other interventional vascular products. Abbott already made a bold entry into cardiovascular devices when it bought Perclose Inc., the leader in arterial closure devices. What's next? Perhaps it could buy Boston Scientific, whose full product line would instantly propel Abbott to the top of the interventional cardiology market.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.